London Daily

Focus on the big picture.
Thursday, Oct 02, 2025

Oxford-AstraZeneca Covid jab safe, insists Hancock

Oxford-AstraZeneca Covid jab safe, insists Hancock

The Oxford-AstraZeneca Covid vaccine is safe, the health secretary has said, after some European nations paused its use amid concern over blood clots.

Matt Hancock urged people to "listen to the regulators" and to "get the jab" as soon as they got the opportunity.

Some 13 countries have suspended use of the vaccine while they seek further clarification on its safety.

But the UK's medicines watchdog, the MHRA, has said that evidence "does not suggest" the jab causes clots.

The EU's regulator, the European Medicines Agency (EMA), is expected to release the findings of its investigation into cases of blood clots in vaccinated people on Thursday.

However, it said previously that it was still "firmly convinced" the benefits of the Oxford-AstraZeneca vaccine outweighed the risks and there was "no indication" the jab causes blood clots.

About 17 million people across the EU and the UK have received a dose of the vaccine, with fewer than 40 cases of blood clots reported as of last week, the manufacturer AstraZeneca said.

It said the number of cases of blood clots reported was lower than the hundreds of cases that would be expected among the general population.

In a bid to reassure the British public, Mr Hancock stressed that the MHRA, the World Health Organization and the European Medicines Agency all believed the vaccine was safe.

"We keep the effects of these vaccines under review all the time and we know that the Oxford-AstraZeneca vaccine is saving lives in the UK right now so if you get the call, get the jab," he said.

Asked if there had been evidence of people declining the jab after the European suspensions, the health secretary said there were still "huge numbers of people vaccinated every day" and that "enthusiasm for getting the vaccine is incredibly strong".


Downing Street has also defended the safety of the vaccine, with the PM's official spokesman insisting that Boris Johnson would be happy to take it when it came to his turn.

Meanwhile, the Duchess of Cornwall revealed on Tuesday that she had received the Oxford-AstraZeneca jab earlier this year.

Speaking during a visit to a pop-up vaccination centre in London with the Prince of Wales, Camilla joked that it "didn't matter" which jab she was given because "I hate injections so much".

The Duchess of Cornwall revealed she received the Oxford-AstraZeneca jab during a visit to a vaccination centre on Tuesday
It was announced in mid-February that Prince Charles, 72, and the duchess, 73, had received their first Covid jabs. Their ages meant they were included in the fourth priority group for the rollout of the vaccine.

The latest government figures show that 24,839,906 first doses of a Covid vaccine have now been given in the UK, with some 1,663,646 people receiving a second dose.

Countries across Europe are seeking further clarity on the jab's safety, amid criticism of their decision to suspend its use.

Denmark was first to pause its use of the vaccine, followed by Norway and Iceland. Germany, France, Italy, Cyprus, Spain, Latvia and Sweden are the latest to follow suit.

Germany, France and Italy have said they are awaiting the outcome of the EMA investigation.

They said they had opted to pause their use of the drug as a "precautionary measure".

Other countries, including Austria, have halted the use of certain batches of the jab, while Belgium, Poland, the Czech Republic and Ukraine said they would continue to administer it.

Dr Phil Bryan, vaccines safety lead at the MHRA, said that people "should still go and get their Covid-19 vaccine when asked to do so".

"We are closely reviewing reports but given the large number of doses administered, and the frequency at which blood clots can occur naturally, the evidence available does not suggest the vaccine is the cause."

The WHO, which is also investigating the reports, says there is no evidence that the clots were linked to the vaccine and it has urged countries not to pause their vaccination programmes.

Prof Jeremy Brown, a member of the UK government's Joint Committee on Vaccination and Immunisation, said concerns about blood clots were "overblown" as they were unlikely to be linked to the jab.

He told BBC Radio 4's Today programme pausing its use would cause more illness and deaths than would be prevented "by the unlikely situation that there's an increased risk of a very rare event occurring as a consequence of the vaccine".

Sir Kent Woods, former chief executive of the MHRA and former chair of the EMA, told BBC Breakfast there would have been a "denting of public confidence because of the disorderly situation in Europe" and by suspending the use of the jab countries were "increasing the risk to the population".

Dr Jess Harvey, a GP in Shropshire, said she had received several calls from patients concerned about the possibility of blood clots linked to the vaccine.

She said she had not had any appointments cancelled yet but was worried about no-shows.

Meanwhile, Public Health England said on Tuesday that it was investigating a new coronavirus variant previously reported by the Philippines, after two cases were identified in England.

It said one case was linked with international travel, while the other was still under investigation.

PHE also said that two cases of the P.1 variant of concern first found in Brazil had been identified in England - with one in the West Midlands and another in Haringey, London.

This variant has a mutation - known as E484 - that means it can escape some of the immune response, which may mean vaccines work less effectively against it.

Both cases were linked with international travel to Brazil, PHE said, and bring the total number of UK cases of the variant to 12.


Health Secretary Matt Hancock: "If you get the call, get the jab"


Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
×